Ankara Onkoloji Eğitim ve Araştırma Hastanesi
In research, Ankara Onkoloji Eğitim ve Araştırma Hastanesi stands highest in Medicine (#8,180 of 10,443 worldwide) and Health Sciences (#9,857 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 10.9× its share of world research.
- World rank, 2022–2025
- #17,729 of 28,054 · #30,149 all time
- Rank in Türkiye
- #234 of 308
- Research works
- 1.4k ▲ 32% vs 2013–17
- Citations
- 4k 2.8 per fractional work
- Top-10% rate
- 6.1% record average 16.5%
- Open access
- 72% world 28%
What is Ankara Onkoloji Eğitim ve Araştırma Hastanesi known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,180 of 10,443 | 4.9% | 250 | #11997 | |
| Health SciencesDomain | #9,857 of 11,982 | 5.1% | 263 | #14158 |
Each strip is that field’s whole ranked pool, with the notch where Ankara Onkoloji Eğitim ve Araştırma Hastanesi sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ankara Onkoloji Eğitim ve Araştırma Hastanesi specialise in?
Where its research is concentrated relative to its size: Oncology takes 10.9× the share of its output that it takes of world research.
- OncologySubfield · 40.2 works11×
- Pulmonary and Respiratory MedicineSubfield · 31.6 works6.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Nursing 1.8×
- Immunology and Microbiology 1.5×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Dentistry 1.3×
- Health Professions 0.9×
- Psychology 0.9×
- Neuroscience 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Veterinary 0.5×
- Physics and Astronomy 0.3×
- Arts and Humanities 0.3×
- Agricultural and Biological Sciences 0.2×
- Economics, Econometrics and Finance 0.2×
- Social Sciences 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Materials Science 0.1×
- Environmental Science 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
- Chemistry 0.0×
Who are the top researchers at Ankara Onkoloji Eğitim ve Araştırma Hastanesi?
Ranked on the composite score, Berna Öksüzoğlu, Halil Başar and Lütfi Doğan lead among researchers whose main affiliation is Ankara Onkoloji Eğitim ve Araştırma Hastanesi.
- 1 Berna Öksüzoğlu Türkiye · #62,641 worldwide 359 citations · 76 works
- 2 Halil Başar Türkiye · #315,412 worldwide 74 citations · 29 works
- 3 Lütfi Doğan Türkiye · #434,106 worldwide 27 citations · 33 works
- 4 Niyazi Karaman Türkiye · #458,461 worldwide 24 citations · 25 works
- 5 Mustafa Ertek Türkiye · #571,508 worldwide 42 citations · 33 works
- 6 D. Erol Türkiye · #589,963 worldwide 0 citations · 20 works
- 7 Erdem Öztürk Türkiye · #763,676 worldwide 13 citations · 22 works
- 8 Fevzi Altuntaş Türkiye · #798,386 worldwide 35 citations · 47 works
- 9 Halil İbrahim Yakut Türkiye · #799,769 worldwide 15 citations · 19 works
- 10 Ali Ayyıldız Türkiye · #809,575 worldwide 20 citations · 36 works
Which keywords describe research at Ankara Onkoloji Eğitim ve Araştırma Hastanesi?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Epidemiology, Inflammation, Prognostic Factors, Radiotherapy, Metastasis and Cancer.
- Soft Tissue Sarcoma
- Health-related Quality of Life
- Breast Tumours
- Radiation Therapy
- Surgery
- Molecular Subtypes
- Immunity
- Anxiety
- Thrombosis
- Mortality
- Metabolic Syndrome
- Neoadjuvant Therapy
- Surgical Management
- Survival Analysis
- Breast Cancer
- Treatment
- Radiotherapy
- Quality of Life
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Inflammation
- Cancer
- Prognostic Factors
- Immunotherapy
- Metastasis
- Prognostic Markers
- Clinical Trials
- Cardiovascular Disease
- Tumor Microenvironment
- Management
- Complications
- Gene Expression
- Guidelines
- Metastatic Breast Cancer
- Genetic Mutations
- Clinical Guidelines
- Prognosis
- Treatment Response
- Prostate Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology32▲ 2.5×79 topics
- Chemotherapy28▲ 12×22 topics
- Inflammation25▲ 3.6×50 topics
- Clinical Practice Guidelines20▲ 11×14 topics
- Cancer18▲ 4.2×26 topics
- Quality of Life17▲ 3.5×31 topics
- Prognostic Factors16▲ 11×14 topics
- Radiotherapy16▲ 12×12 topics
- Immunotherapy15▲ 6.3×14 topics
- Treatment14▲ 3.6×37 topics
- Metastasis14▲ 12×8 topics
- Breast Cancer14▲ 18×11 topics
- Prognostic Markers12▲ 34×3 topics
- Survival Analysis12▲ 13×6 topics
- Clinical Trials12▲ 5.3×15 topics
- Surgical Management11▲ 8.4×16 topics
- Cardiovascular Disease11▲ 3.0×27 topics
- Neoadjuvant Therapy10▲ 14×5 topics
- Tumor Microenvironment10▲ 6.6×7 topics
- Metabolic Syndrome9▲ 3.4×18 topics
- Management9▲ 3.4×20 topics
- Mortality8▲ 4.5×10 topics
- Complications8▲ 5.0×15 topics
- Thrombosis8▲ 8.4×5 topics
- Gene Expression8▲ 3.8×8 topics
- Anxiety8▲ 4.8×8 topics
- Guidelines8▲ 4.9×11 topics
- Immunity7▲ 5.5×5 topics
- Metastatic Breast Cancer7▲ 39×2 topics
- Molecular Subtypes7▲ 26×3 topics
- Genetic Mutations7▲ 5.0×16 topics
- Surgery7▲ 6.1×9 topics
- Clinical Guidelines7▲ 7.1×6 topics
- Radiation Therapy6▲ 15×5 topics
- Prognosis6▲ 6.0×8 topics
- Breast Tumours6▲ 41×1 topic
- Treatment Response6▲ 41×1 topic
- Health-related Quality of Life6▲ 7.6×5 topics
- Prostate Cancer6▲ 14×4 topics
- Soft Tissue Sarcoma6▲ 32×2 topics
Which research topics does Ankara Onkoloji Eğitim ve Araştırma Hastanesi publish most on?
By volume in 2022–2025: Breast Cancer Treatment Studies, Inflammatory Biomarkers in Disease Prognosis, Sarcoma Diagnosis and Treatment and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Breast Cancer Treatment Studies Cancer Research 6 works
- 2 Inflammatory Biomarkers in Disease Prognosis Oncology 5 works
- 3 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 5 Nutrition and Health in Aging Physiology 4 works
- 6 Bone Tumor Diagnosis and Treatments Rheumatology 4 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 8 Cancer Treatment and Pharmacology Oncology 4 works
- 9 Ovarian cancer diagnosis and treatment Reproductive Medicine 4 works
- 10 HER2/EGFR in Cancer Research Oncology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ankara Onkoloji Eğitim ve Araştırma Hastanesi's research output changed?
Output in 2018–2022 was 32% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ankara
- Hacettepe University
- Ankara University
- Gazi University
- Middle East Technical University
- Bilkent University
- Başkent University
- Gazi Hastanesi
- Ankara Sosyal Bilimler Üniversitesi
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.